Health-related quality of life of daily-life-affected benign essential blepharospasm: Multi-center observational study.
Parima HirunwiwatkulWajamon SupawatjariyakulSupharat JariyakosolSupanut ApinyawasisukJiruth SriratanabanYuda ChongpisonPriya JagotaNipat Aui-AreeJuthamat WitthayaweerasakSuwanna SetthawatcharawanichKitthisak KitthaweesinNiphon ChirapapaisanPiyawadee ChaimongkoltrakulPoramaet LaowanapibanLinda HansapinyoSuthida PanpitpatSireedhorn KurathongJirat NimworaphanSuntaree ThitiwichienlertKavin VanikietiNarong SamipakWorapot SrimananNattapong MekhasingharakPareena ChaitanuwongPublished in: PloS one (2023)
Daily-life-affected BEB impacted HRQOL in most dimensions from both generic and visual-specific questionnaires. BTX-A treatment not only decreased disease severity, but also improved quality of life.